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Abstract
MAP kinase signaling has been implicated in brain development, long-term memory, and the response to antidepressants.
Inducible Braf knockout mice, which exhibit protein depletion in principle forebrain neurons, enabled us to unravel a new
role of neuronal MAPK signaling for emotional behavior. Braf mice that were induced during adulthood showed normal
anxiety but increased depression-like behavior, in accordance with pharmacological findings. In contrast, the inducible or
constitutive inactivation of Braf in the juvenile brain leads to normal depression-like behavior but decreased anxiety in
adults. In juvenile, constitutive mutants we found no alteration of GABAergic neurotransmission but reduced neuronal
arborization in the dentate gyrus. Analysis of gene expression in the hippocampus revealed nine downregulated MAPK
target genes that represent candidates to cause the mutant phenotype. Our results reveal the differential function of
MAPK signaling in juvenile and adult life phases and emphasize the early postnatal period as critical for the determination of
anxiety in adults. Moreover, these results validate inducible gene inactivation as a new valuable approach, allowing it to
discriminate between gene function in the adult and the developing postnatal brain.
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Introduction
The extracellular signal-regulated kinase/mitogen-activated
protein kinase (ERK/MAPK) signaling pathway is a linear kinase
cascade with a well-understood biochemistry. Cell surface
receptors activate the small GTPase RAS, which itself activates
Raf kinases. RAF phosphorylates and activates MEK1 and MEK2
that in turn phosphorylate and activate ERK1 and ERK2 kinases.
Finally, activated ERKs either translocate into the nucleus to
phosphorylate transcription factors, or directly regulate cytoplas-
mic substrates. ERK/MAPK signaling is known as a key player in
basic cellular processes like growth, differentiation, survival, and
apoptosis. Among the three mammalian Raf isoforms, B-RAF is
the strongest MEK-ERK activator expressed in neuronal tissues
and testis [1] and was shown to be a protooncogene [2].
Furthermore, other members of the ERK/MAPK signaling
pathway cause the developmental RAS/MAPK or neuro-cardio-
facial-cutaneous (NCFC) syndromes [3,4].
In the nervous system, the ERK/MAPK signaling pathway is
known to participate in long-term potentiation, synaptogenesis,
and dendritic differentiation. The global inactivation of B-RAF
causes a shutdown of MEK1/2 kinases as exclusive substrates and
the resulting depletion of ERK/MAPK signaling leads to
embryonic lethality [5]. However, conditional, brain-specific Braf
knockout mice allow to investigate the role of ERK/MAPK
signaling in the nervous system. Thereby it was shown, that Braf is
essential for long-term potentiation, learning and memory, and
synaptic plasticity [6–8]. Moreover, ERK/MAPK signaling was
linked to neuronal differentiation, axonal growth [9], oligoden-
drocyte maturation [10], and is associated with autism [11] and
the development of depression [12].
In matters of emotional behavior, the acute pharmacological
inhibition of the ERK/MAPK signaling using the MEK inhibitor
PD184161 leads to depression-like behavior in mice [13]. In
addition, activation of ERK/MAPK signaling was found upon
treatment with different mood stabilizers like lithium [14,15] and
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valproic acid [15,16]. However, currently little is known about the
involved downstream targets of the ERK/MAPK signaling in the
brain and about the intracellular cascades and interactions
involved in the regulation of anxiety and depression.
To decipher the role of ERK/MAPK signaling for emotional
behavior, we studied conditional mouse mutants in which the Braf
gene becomes inactivated in principle forebrain neurons upon
induction in the juvenile or adult brain and compared them to
mutants that undergo constitutive inactivation of Braf in the
juvenile brain. We found that the inactivation of Braf in the
juvenile or adult brain differentially affects their depression-like
behavior or anxiety as adults. Mutants that undergo constitutive
inactivation of Braf in the juvenile brain were further characterized
for alterations of GABAergic neurotransmission, the dendritic
complexity of hippocampal neurons, and the global gene
expression profile in the hippocampus to identify key targets of
neuronal ERK/MAPK signaling. These results reveal a differen-
tial function of ERK/MAPK signaling in juvenile and adult life
phases and emphasize the early postnatal period as critical for the
determination of anxiety in adults.
Methods
Animals and treatments
To generate conditional mutants, Brafflox mice (initially derived
from R1 ES cells of the 129X1/SvJ6129S1/Sv (‘‘129/Sv’’) F1
hybrid background) [6] were obtained on a mixed ‘‘129/Sv’’ and
FVB genetic background and backcrossed to C57BL/6J mice
(obtained from Charles River Germany) for three generations.
Braficko mice were generated by breeding of Brafflox mice with
transgenic CamkIIa-CreERT2 mice (initially derived on the FVB
background) [17], that were backcrossed to C57BL/6J mice for 9
generations. Brafcko mice were generated by breeding of Brafflox
mice with transgenic CamkIIa-Cre mice (initially derived on a
(CBA/J6C57BL/6J)-F2 background; [18] and R. Ku¨hn, unpub-
lished results) that were backcrossed to C57BL/6J mice for more
than 20 generations.
To obtain experimental cohorts, males homozygous for the
Brafflox allele were mated with females that were heterozygous for
the Brafflox allele and heterozygous for the CamkIIa-Cre or
CamkIIa-CreERT2 transgene. Littermates homozygous for the
Brafflox allele without Cre transgene were used as controls, whereas
littermates homozygous for the Brafflox allele and heterozygous for
the Cre transgene were used as mutants. This breeding scheme
resulted into experimental groups of Brafcko mice with a mean
genetic contribution of 93.7% derived from C57BL/6J, of 6.2%
from FVB, and of 0.1% from ‘‘129/Sv’’. The experimental groups
of Braficko mice exhibited a similar genetic background derived to
93.4% from C57BL/6J, to 6.5% from FVB, and to 0.1% from
‘‘129/Sv’’. In experiments with Braficko mice, both mutants and
controls were treated with tamoxifen to account for potential non-
specific effects of the inducing compound.
Using this breeding scheme, the ‘‘flanking allele problem’’
[19,20] was avoided for the Brafflox allele, but could not be
excluded for the chromosome harboring the heterozygous Cre
transgene. To account for a potential phenotypic effect of the
CamkII-Cre transgene and its flanking alleles, we compared the
behavior of 29 transgenic and 29 non-transgenic CamkII-Cre
littermates in the modified holeboard (see Method S2), elevated-
plus-maze (EPM), forced swim test (FST), and the accelerating
rotarod (see Method S2). This analysis showed that CamkII-Cre
transgenic littermates did not exhibit significant differences for the
EPM time in open arms, the FST immobility time, the
performance on the rotarod, and other parameters (Figure S3).
With respect to the CamkIIa-CreERT2 transgene we can presently
not exclude a potential phenotypic effect of alleles flanking the
heterozygous transgene. However, the mutants that were induced
at the age of 3–4 weeks or 8–9 weeks exhibit the same genetic
background.
Controls and knockouts were group-housed with food and water
ad libitum in individually ventilated cages under standard
laboratory conditions as previously described [21]. Animals were
separated based on sex, but not genotype. Induction of Cre in
Braficko mice was achieved by 10 i.p. injections of 40 mg/kg b. wt.
tamoxifen (free base, Sigma; solved in 9:1 sunflower seed oil/
ethanol) during five consecutive days. Behavioral testing started at
the earliest two weeks after tamoxifen treatment.
Immunohistochemistry
Mice were euthanised and intracardially perfused with saline,
followed by 4% paraformaldehyde in PBS. Brains were prepared,
postfixed for 2 h in 4% PFA, and cryoprotected with 25% sucrose
in PBS. 40 mm thick, free-floating cryo sections were cut on a
microtom and stored in a cryoprotectant. For immunohistochem-
istry, sections were washed in PBS, bleached with 0.3% H2O2 in
1:1 PBS/methanol for 15 min, and blocked with 5% FCS in PBS-
T (0.2% Triton-X in PBS) for 30 min at RT. For detection of
phosphorylated proteins, TBS was used instead of PBS in all steps.
Sections were incubated with rabbit a-BRAF (H-145, 1:100, Santa
Cruz Biotechnology, Heidelberg, Germany) or a-Phospho-p44/42
MAPK (#9101, 1:50, Cell Signaling Technology, Frankfurt,
Germany), respectively, overnight at 4uC, washed with PBS, and
incubated with biotin-conjugated a-rabbit antibody (1:300,
Dianova, Hamburg, Germany) for 2 h at RT. For detection, the
Vectastain ABC kit (Vector Laboratories, Peterborough, UK) was
used and the sections were then mounted, dehydrated, and
covered with a resinous mounting medium.
Western blot analysis
Fresh brain samples were homogenized in RIPA buffer (50 mM
Tris-HCl pH 7.4, 1% NP-40, 0.25% sodium deoxycholate,
150 mM NaCl, 1 mM EDTA, protease inhibitor) and protein
concentrations were determined by the BCA assay prior to loading
on 10% Bis-tris acrylamid gels. After electrophoresis, the proteins
were transferred onto PVDF membranes. Next, membranes were
blocked with 4% skim milk in TBS-T, incubated with the primary
antibodies, washed with TBS-T, and incubated with horseradish-
peroxidase-conjugated secondary antibodies (goat a-rabbit,
1:5 000, Dianova; goat a-mouse, 1:1 000, Dianova). Signals were
visualized with an enhanced chemiluminescence assay (ECL Plus,
Amersham, Freiburg, Germany) and quantified with a fluores-
cence image analyzer. Primary antibodies used were: rabbit a-
BRAF, C-19, 1:600, Santa Cruz Biotechnology; rabbit a-pERK1/
2, #9101, 1:1 000, Cell Signaling Technology; rabbit a-ERK1/2,
#9102, 1:1 000, Cell Signaling Technology; mouse a-bACTIN,
AC-15, 1:100 000, Abcam, Cambridge, UK.
Behavioral testing
For Braficko/juvenile behavioral analysis, 26–29 controls and 16–
17 mutants were tested in the elevated plus maze and the forced
swim test (in this order). For Braficko/adult behavioral analysis, 29
controls and 29–31 mutants were tested in the elevated plus maze
and the forced swim test (in this order). The minimal inter-test
interval in all experiments was 6 days. For Brafcko behavioral
analysis, 27–29 controls and 22–26 mutants were tested in a first
experiment in the light/dark box and the tail suspension test at the
age of 16–17 and 24–25 weeks, respectively. A second batch of
Brafcko mice, consisting of 24–26 controls and 24–28 mutants, was
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tested in the elevated plus maze and the forced swim test at the age
of 22–23 and 28–29 weeks, respectively. Comparable numbers of
male and female animals were used in all experiments.
Elevated plus maze. The test arena was made of light grey
PVC and consisted of two open arms (306560.3 cm) and two
closed arms of the same size with 15 cm walls. The open arms and
accordingly the closed arms were facing each other connected via
a central square (565 cm). The apparatus was elevated 75 cm
above the floor by a pole fixed underneath the central square. The
illumination level was set at approximately 100 lux in the centre of
the maze. For testing, each mouse was placed at the end of a
closed arm (distal to the centre) facing the wall and was allowed to
explore the maze for 5 min. A camera was mounted above the
centre of the maze to video monitor each trial by a trained
observer in an adjacent room. The number of entries into each
type of arm (placement of all four paws into an arm defining an
entry), latency to enter the open arms as well as the time spent in
the open and closed arms were recorded by the observer with a
hand-held computer. Data were analyzed by using the Observer
4.1 Software (Noldus). After each trial, the test arena was cleaned
carefully with a disinfectant.
Light/dark box. The test box was made of PVC and divided
into two compartments, connected by a small tunnel (46669 cm
high). The lit compartment (29619624 cm high) was made of
white PVC and was illuminated by cold light with an intensity of
650 lux in the middle; the dark compartment (14619624 cm
high) was made of black PVC and not directly illuminated
(approx. 20 lux in the centre). The mouse was placed in the centre
of the black compartment and allowed to explore freely the
apparatus for 5 min. Behaviors were observed by a trained
observer next to the box using a hand-held computer. Data were
analyzed with respect to (1) the number of entries, latency to first
entry, and time spent in both compartments, and the tunnel; (2)
the number of rearings in both compartments and the tunnel.
Additionally, grooming behavior was recorded. An entry into a
compartment was defined as placement of all four paws into the
compartment. Additionally, a camera was mounted above the
centre of the test arena to videotape the trial, and the animal’s
locomotor path in the lit compartment was analyzed with a video-
tracking system (Ethovision 2.3, Noldus). The box was cleaned
with a disinfectant before each trial.
Forced swim test. The forced swimming test was adapted
from Ebner et al. [22]. The forced swimming apparatus consisted
of a cylindrical 10 L glass tank (24.5 cm in diameter) filled to a
depth of 20 cm with water (2561uC). A trained observer recorded
the animals behavior in moderate lighting conditions (approx.
30 lux) for 6 min with a hand-held computer scoring the following
behaviors: (1) struggling, defined as movements during which the
forelimbs broke the water’s surface; (2) swimming, defined as
movement of the animal induced by movements of the fore and
hind limbs without breaking the water surface, and (3) floating,
defined as the behavior during which the animal used limb
movement just to keep its balance without any movement of the
trunk. Data were analyzed by using the Observer 4.1 Software
(Noldus). After each trial, the mouse tested was dried with a tissue
and put in a new cage, and the water was renewed before testing
the next animal.
Tail suspension test. For the tail suspension test, each
mouse was hung by the base of its tail, fixed with a tape, for 6 min.
A trained observer recorded with a hand-held computer the
animal’s behavior scoring activity and immobility. Data were
analyzed by using the Observer 4.1 Software (Noldus).
Ethics Statement
Experiments on animals were carried out in accordance with
the European Community Council Directive of 24 November
1987 (86/609/EEC). All animal experiments were approved by
the animal welfare and use committee of the local governmental
body (Regierung von Oberbayern, approval numbers 2531-47/03
and -70/07).
Voluntary wheel running activity
All mice were kept in a 1/23 h light/dark cycle in order to
synchronize the circadian activity while preventing the resting
phase activity to be affected by light stimuli. 10 control and 10
Brafcko mutant mice (4 females and 6 males each) were housed
individually during the experiment in a separate, sound and light
insulated room and had access to food and water ad libitum.
Activity was measured with a Low Profile Wireless Running
Wheel (Med Associates Inc., St. Albans, VT, USA) for 17 days and
the data was analyzed with the CHRONO software [23].
Slice electrophysiology
Using standard procedures, transverse hippocampal slices
(350 mm thick) were prepared from the brain of male adult
Brafcko mice, which were deeply anesthetized with halothane prior
to decapitation. The slices were initially maintained in a high-
sucrose solution containing (in mM) 75 sucrose, 87 NaCl, 3 KCl,
0.5 CaCl2, 7 MgCl2, 1.25 NaH2PO4, 25 NaHCO3 and 10 D-
glucose. The solution was ice-cold for cutting and warmed to 35uC
for 20 minutes immediately after that. The slices were then
incubated in modified artificial cerebrospinal fluid (ACSF)
containing (in mM) 125 NaCl, 3 KCl, 1 CaCl2, 3 MgCl2, 1.25
NaH2PO4, 25 NaHCO3 and 10 D-glucose at room temperature
(21–24uC) for at least 2 hours before being transferred into the
recording chamber individually. Recordings were performed at
room temperature in normal ACSF containing (in mM) 125 NaCl,
3 KCl, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 25 NaHCO3 and 10
D-glucose (pH 7.4), which was exchanged by means of a gravity-
driven perfusion system (flow rate 2–3 mL/min). All solutions
were constantly gassed with 95% O2/5% CO2. CA1 pyramidal
cells were visualized with a contrast-enhanced CCD camera
(Hamamatsu Photonics, Herrsching, Germany). Electrophysiolog-
ical signals were filtered at 1 kHz (for field potentials) or 2 kHz (for
whole-cell currents) and sampled at 10 kHz using a Multiclamp
700B amplifier in conjunction with Digidata 1440A interface and
pClamp 10 software (all from Molecular Devices, Sunnyvale, CA,
USA). CA1 pyramidal cell population spike (PS) was induced by
constant current pulses (pulse width 0.1 ms, every 10 s) delivered
to a bipolar tungsten electrode located in CA1 stratum radiatum.
The extracellular recording pipette in pyramidal cell layer was
filled with modified ACSF, in which bicarbonate was replaced
with Hepes to avoid pH change. For whole-cell recording of the
evoked inhibitory postsynaptic currents (IPSC) in CA1 pyramidal
cells, patch pipettes were filled with solution containing (in mM)
130 CsCl, 3 MgCl2, 5 EGTA, 5 Hepes, 2 Na2-ATP, 0.3 Na-GTP
and 5 QX-314 (pH 7.25). The electrode resistance ranged from
2.5 to 4 MV when filled with internal solution. Series resistance in
whole-cell configuration was about 10–25 MV, which was
compensated by 60–80%. Constant current pulses (pulse width
0.1 ms) of 50–200 mA were delivered every 30 s to the concentric
bipolar electrode located close to the pyramidal cell layer. IPSCs
were recorded at 270 mV, after correcting for liquid junction
potentials. GABAA receptor-mediated IPSCs were pharmacolog-
ically isolated by perfusing the slices with ionotropic glutamate
receptor antagonist kynurenic acid (2 mM). All the drugs were
obtained from Sigma. Data were analyzed off-line with Clampfit
MAPK Signaling in Emotional Behavior
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(Molecular Devices). The PS amplitude was calculated as the
averaged value from negative peak to two positive peaks. For
evoked IPSCs, we determined peak amplitude, time width at half
peak amplitude (T1/2) and area above the curve. Spontaneous
IPSCs were analyzed using an automated event detection
algorithm with an amplitude threshold set as 4 * snoise. The
frequency was measured for spontaneous IPSCs.
Gene expression analysis
Five male Brafcko and six male homozygous Brafflox littermates
were killed with CO2, the complete hippocampal tissue was
prepared, and total RNA was extracted with the Trizol protocol.
The integrity and quality of the RNA samples were analyzed with
an RNA electrophoresis chip (RNA 6000 Nano Kit, Agilent,
Boeblingen, Germany). RNA samples of high integrity and quality
(RIN$7.5) were further processed with the TotalPrep RNA
Amplification Kit (Ambion, Austin, TX, USA) and hybridized
onto MouseWG-6 v1.1 Expression BeadChips (Illumina, San
Diego, CA, USA) following manufacturer’s instructions. Data
were analyzed using the software R [24] (used packages:
beadarray, limma, and vsn). Our microarray data is MIAME
compliant and the raw data has been deposited in the NCBI’s
Gene Expression Omnibus (GEO) database (GEO accession
number: GSE33618). For validation of the microarray results, the
expression of 22 genes was analyzed by qPCR either with
predesigned TaqMan assays (Applied Biosystems, Darmstadt,
Germany) or with selfdesigned primer pairs for SYBR Green
Assays (Applied Biosystems).
Neuronal morphology
Two female Brafcko and two female control mice were sacrificed
with CO2 and brains were prepared and stored in PBS. Golgi
impregnation was performed with the FD Rapid GolgiStain Kit
(FD NeuroTechnologies, Ellicott City, MD, USA) according to the
manufacturer’s protocol. Briefly, whole brain hemispheres were
impregnated for 14 days at RT in solution A+B, cleared for 3 days
in solution C, and then cut with a cryostat in 140 mm coronal slices
and mounted onto glass slides. After staining with solution D+E,
the slides were dehydrated and covered with a resinous mounting
medium. All incubation steps were performed in a dark room.
Dendritic morphology was analyzed by manual tracing using the
Neurolucida software (MBF Bioscience, Williston, VT, USA).
Only granular neurons of the dentate gyrus with a non-truncated
dendritic tree and a thorough staining were used for tracing
(controls: 138 neurons, mutants: 72 neurons). For analysis of
dendritic length and Sholl analysis, the Neuroexplorer software
(MBF Bioscience) was used.
Statistical analysis
All data are reported as the means 6 S.E.M. unless otherwise
stated. Statistical comparisons were performed by Student’s t-test
or by analysis of variance (ANOVA) with the SPSS software (SPSS
Inc., Chicago, IL, USA). The accepted level of significance was
P,0.05. For statistical analysis of behavioral data, we performed
first a two-way ANOVA with sex as independent variable to check
for sex6genotype interactions. Since no interactions were found,
data from male and female mice were pooled and Student’s t-tests
or one-way ANOVAs were performed on the pooled samples. For
the sake of clarity, only pooled data are presented in the figures
and reported in the results section.
As observations of neuronal morphology were made in cells
with several cells from each of 2 wildtypes and 2 mutants, linear
mixed-effects models with animal as random effect variable were
applied to perform group comparisons and calculate confidence
intervals. For all calculations, the R software [24] with the nlme
package [25] was used.
Results
Generation of inducible Braf knockout (Braficko) mice
The characterization of ERK/MAPK function specifically in
the juvenile or the adult brain requires a timed control of gene
inactivation. For this purpose, and since the complete loss of Braf
leads to embryonic lethality [5], we used a tamoxifen-inducible
CamkIIa-CreERT2 mouse line that exhibits inducible Cre activity
in principal neurons of the cortex, hippocampus, medial striatum,
and hypothalamus [17]. By crossing CamkIIa-CreERT2 with
Brafflox mice [6], we generated inducible conditional Braf knockout
(‘‘Braficko’’) mice, in which the inactivation of Braf is restricted to
neurons that express Cre recombinase and delete exon 14 of the
Brafflox allele (Figure S1A). As both, control and mutant Braficko
mice are homozygous for the loxP flanked Braf allele, these groups
do not differ with respect to alleles flanking the targeted locus
[19,26]. Using a Cre reporter strain, we confirmed the reported
recombination pattern of CamkIIa-CreERT2 mice [17] and
further found that recombination can be induced in the brain of
juvenile (3-weeks-old), adolescent (6-weeks-old), and adult mice
(14-weeks-old) at equal efficiency (Figure S1B).
Emotional behavior of adult and juvenile Braficko mice
Adult or juvenile Brafflox/flox;CreERT2 and Brafflox/flox mice were
both treated for 5 days with tamoxifen and classified as Braficko
mutants and treated controls, respectively. Braficko mice were first
induced at 8.5 weeks (‘‘Braficko/adult mutants and controls’’) to test
for ERK/MAPK function specifically in the adult forebrain,
excluding postnatal developmental effects (Figure 1A). Four weeks
after the completion of induction Braficko/adult mice were analyzed
for anxiety-related and depression-like behavior in the elevated
plus maze (EPM) and the forced swim test (FST) respectively,
followed by the confirmation of BRAF depletion in brain sections
(Figure 1E). Interestingly, in the FST the Braficko/adult mutants
showed significantly increased passive behavior (Figure 1G;
t[58] = 3.943; P,0.001) whereas in the EPM no differences
compared to controls were found (Figure 1F). These results
indicate an increase of depression-like behavior and normal
anxiety-like behavior in Braficko/adult mutants. Next, Braficko mice
were induced early postnatal at 3 weeks of age (‘‘Braficko/juvenile
mutants and controls’’) to cause juvenile inactivation of ERK/
MAPK signaling in forebrain neurons (Figure 1A). At the age of 8
weeks Braficko/juvenile mice were analyzed for anxiety-related and
depression-like behavior in the EPM and FST. Upon completion
of the phenotype analysis, the depletion of the BRAF protein in
forebrain regions of Braficko/juvenile mutants was confirmed by
immunohistochemistry (Figure 1B). Braficko/juvenile mutants spent
significantly more time in the open arms of the EPM (Figure 1C;
t[40] = 3.513; P,0.01), whereas no difference in the passive
behavior in the FST was observed (Figure 1D). These results
indicate a normal depression-like behavior but decreased anxiety
of adults upon Braf depletion in the juvenile brain. Taken together,
these results suggest a differential role of ERK/MAPK signaling
for emotional behavior in the juvenile versus the adult brain. In
agreement with previous results from pharmacological interven-
tion, the inhibition of ERK/MAPK signaling in the adult brain
causes increased depression-like behavior. In contrast, the early
deficiency of ERK/MAPK activity in the postnatal brain between
4 and 8 weeks leads to strongly decreased anxiety, but unaltered
depression-like behavior of adults. Therefore, neuronal ERK/
MAPK signaling is essential to establish normal anxiety- or
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depression-like behavior, in dependence on the timing of gene
inactivation. Since in the juvenile brain, neuronal ERK/MAPK
signaling is a critical component to establish normal anxiety, we
assume that an early ERK/MAPK deficiency causes long lasting
alterations in brain development.
Generation of constitutive Braf knockout (Brafcko) mice
To further analyze developmental alterations in the juvenile brain
we continued our studies using forebrain-specific, early postnatal
conditional Braf mutants which render the stressful application of
tamoxifen for inducing the knockout unnecessary. These condition-
al Braf mutants (‘‘Brafcko’’) were generated by the cross of Brafflox
micewith theCamkIIa-Cre line [18]. In Brafckomice, inactivation of
the Braf gene in principal forebrain neurons begins 2 weeks after
birth and is complete at the age of 6 weeks (as shown by Southern
blot analysis, Figure S2B) leading to a strong reduction or complete
abolishment of ERK/MAPK signaling in affected neurons
(Figure 2B), which recapitulates the spatial and temporal inactiva-
tion ofBraf in Braficko/juvenile mutants (Figure 2A and S2). To rule out
possible effects of theCre transgene on behavior, CamkIIa-Cremice
(backcrossed .20 generations to the C57BL/6J background) were
compared to non-transgenic littermates for anxiety- and depression-
related parameters. This analysis showed that the CamkII-Cre
transgene does not cause significant differences in behavior
compared to wildtype littermate controls (Figure S3).
Emotional behavior and activity pattern of Brafcko mice
The anxiety-related behavior of Brafcko mice was assessed in the
EPM and light/dark box (LD). In both tests we found that Brafcko
mice spent significantly more time in the aversive compartments
Figure 1. Comparison of emotional behaviors between early and late induced Braficko mice. (A) Scheme of experimental procedure:
Juvenile and early adult Braficko mice were induced with tamoxifen at an age of 3–4 and 8.5–9.5 weeks, respectively (black arrowheads) and
behavioral analysis started at week 8 and 16, respectively (white arrows). (B,E) Immunohistochemical detection of BRAF of juvenile (B) and early adult
(E) Braficko mice revealed depletion of the protein in principle neurons of the hippocampus (shown) and the cortex (not shown). Scale bars represent
500 mm. (C,F) In the elevated plus maze, a less anxious behavior was observed in Braficko/juvenile (C), but not in Braficko/adult mice (F). (D,G) In the
forced swim test, Braficko/adult mice displayed an increase in depression-like behavior (G) that was not present in juvenile induced Braficko mice (D)
(n.s.: not significant, **: P,0.01, ***: P,0.001). (H) Immunohistochemical detection of Phospho-ERK1/2 in Braficko/juvenile mice demonstrated a strong
reduction of ERK/MAPK signaling in principle neurons of the hippocampus of Braficko mutants. Scale bars represent 500 mm.
doi:10.1371/journal.pone.0035035.g001
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than the controls (EPM open arms, Figure 2C; t[47] = 3.912;
P,0.001) (LD lit compartment, Figure 2D; t[53] = 3.889; P,0.001),
suggesting a reduced anxiety-related behavior of Braf deficient mice.
Other behavioral parameters like the total distance travelled, the
mean velocity, and the number of entries in the EPM and LD zones
were not different between the groups (data not shown). In both
paradigms for behavioral despair, Brafcko mutants showed no
differences in their depression-like behavior. In the FST (Figure 2E),
as well as in the tail suspension test (TST, Figure 2F), the total
duration of passive behavior (immobility) was unchanged between
mutant and control animals, indicating no effect of theBraf knockout
on depression-like behavior. In conclusion, Brafcko mutants showed,
like Braficko/juvenile mutants, reduced anxiety-like behavior but
normal depression-like behavior. Notably, the behavioral changes
due to the juvenile depletion of ERK/MAPK signaling are
independent of the time point of behavioral testing (early adult in
Braficko/juvenile and late adult in Brafcko).
ERK/MAPK signaling has been proposed as regulator of
circadian rhythms in the suprachiasmatic nucleus [27,28]. To
examine whether Brafcko mice exhibit an altered circadian
rhythm, we measured their voluntary wheel running activity in a
1/23 h light/dark experiment for 17 days. As shown for two
representative mice in Figure 3A, there was no general shift of time
of activity between mutants and controls. Both genotypes
synchronized the beginning of their activity phase to ,4 pm.
Interestingly, mutant mice showed a much more fragmented
activity pattern and a less distinct end point of their activity.
Moreover, Brafcko mice showed a significantly increased activity
during the resting phase compared to the floxed controls
(Figure 3B; t[225] = 4.266; P,0.001). Despite these different
patterns, the overall diurnal period length was not changed in
the Brafcko mice (Figure 3C). In contrast, the mean daily activity,
measured by the total distance moved per day, was significantly
reduced in the Braf cKOs (Figure 3D; t[329] = 6.772; P,0.001).
Analysis of GABAergic signaling of Brafcko mice
GABAergic neurotransmission is intimately involved in the
regulation of emotional behavior and GABAA receptors are well-
established targets of anxiolytic drugs. Furthermore, a direct
regulation of GABAA receptors by ERK mediated phosphoryla-
tion has been demonstrated [29]. Therefore, increased GABAergic
neurotransmission may contribute to the altered emotional
phenotype of Brafcko mice. In a first set of experiments, we
performed extracellular recordings of population spikes of CA1
pyramidal cells in hippocampal slices of Brafcko and control mice.
Determination of input-output relationships, in which population
spike amplitudes were plotted as function of increasing stimulus
strength, demonstrated proper functioning of the Schaffer-CA1
synapse in hippocampi from both genotypes under conditions of
low-frequency stimulation (Figure S4A). Pharmacologic suppres-
sion of GABAA receptor-mediated inhibition by the GABAA
receptor antagonist picrotoxin produced a strong enhancement of
the population spike amplitude that was virtually indistinguishable
between hippocampi from the two genotypes (Figure 4A). We next
performed whole-cell recordings from voltage-clamped CA1
pyramidal cells to directly examine and compare pharmacologi-
cally isolated inhibitory postsynaptic currents (IPSCs) in the two
preparations. In none of these recordings, we obtained evidence
for enhanced GABAergic neurotransmission in mutant hippo-
campi (Figure S4B–D). Furthermore, IPSCs from CA1 pyramidal
cells of Brafcko mice proved as sensitive to the augmenting effect of
diazepam as those from controls (Figure 4B). These results argue
against the notion that up-regulation of GABAA receptor-
mediated inhibition underlies or appreciably contributes to the
altered emotional behavior of Brafcko mutants.
Neuronal arborization in the hippocampus of Brafcko
mice
Alterations in emotional behavior are often associated with
changes in dendritogenesis and spine density [30–33]. Since the
microarray analysis of Braf mutants (see below) identified
Figure 2. Molecular analysis and emotional behavior of Brafcko
mice. (A) Immunohistochemical detection of BRAF of Brafcko mice
revealed depletion of the protein in the hippocampus (shown) and the
cortex (not shown). (B) Western blot analysis of hippocampal samples
of Brafcko mice validates the depletion of BRAF protein and the
subsequent inactivation of ERK/MAPK signaling. While total levels of
ERK1/2 in Brafcko mice were unaffected, a strong reduction, but no
complete depletion of Phospho-ERK1 and -ERK2 was observed in the
hippocampus of mutants. The remaining ERK1/2 activity in Brafcko
forebrain regions likely results from non-glutamatergic neuronal or glial
cells that express BRAF, but which do not express the CamkIIa-Cre
transgene (see Figure S2I). (C) Elevated plus maze: Mutant mice spent
significantly more time in the open arms of the maze. (D) Light/dark
box: Braf mutants spent more time in the aversive lit compartment.
(E,F) No changes in depression-like behavior were observed in Brafcko
mutants in the forced swim test (E) and the tail suspension test (F). (n.s.:
not significant, ***: P,0.001).
doi:10.1371/journal.pone.0035035.g002
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differentially expressed genes related to neuronal growth, devel-
opment, and arborization (Table S2), we performed Golgi
stainings of dentate gyrus granular neurons of Brafcko mice. This
analysis revealed that the total and the mean length of dendrites
were significantly reduced in these cells (Figure 5B; total length:
P,0.05, mean length: P,0.05). Sholl analysis of the tracing data
showed that in Braf mutants both the number of intersections
(Figure 5E) and the interradial length of the dendritic arbores
(Figure 5F) are strongly decreased in the distance of 80–160 mm
(intersections) and 90–160 mm (interradial length) from the soma,
respectively. These results demonstrate an overall reduction of the
complexity of granular neurons by an impaired arborization in the
Braf mutants. In contrast, the spine density and tortuosity of
dentate gyrus granular neurons were not significantly different
between Braf mutants and controls (Figure 5C and D), indicating
that ERK/MAPK signaling does not control spine formation and
dendritic routing.
Global gene expression analysis in the hippocampus of
Brafcko mice
A major molecular function of ERK/MAPK signaling is the
regulation of gene expression by the activation of transcription
factors. To identify genes that are controlled by ERK/MAPK
signaling in principle forebrain neurons, we compared the global
gene expression in the hippocampus of adult Brafcko and Brafflox
control males. This analysis revealed 111 genes that were
downregulated (Padj,0.05) and 39 genes that were upregulated
(Padj,0.05) in Braf
cko mice (Table S1). To control for the impact of
the Cre transgene on gene expression, we compared the
hippocampal gene expression of CamkIIa-Cre and wildtype
littermates. This analysis revealed four differentially expressed
transcripts (3110047M12Rik, Oxr1 [2 transcripts], Zfpm2; Table
S1) that were excluded from the further study. For validation of
the microarray data by qPCR, we selected 22 transcripts
representing transcription factors (e.g. Egr1, Egr4, Etv5), immediate
early genes (e.g. Bdnf, Egr1, Egr4), genes related to behavior (e.g.
Npy, Bdnf, Cck), to neuronal development (e.g. Bdnf, Klk8, Etv1), and
Figure 3. Daily voluntary wheel running activity in Braf mutants and controls. (A) Representative actograms of Brafcko and control mice.
The Brafcko mouse (lower panel) showed a much more fragmented pattern in a LD 1:23 experiment compared to its floxed littermate (upper panel).
Vertical white bar represents daily light phase. (B) Activity during resting phase is significantly increased in Brafcko mice. (C) Period length analysis
revealed no differences between floxed (23.7860.04) and Brafcko mice (23.8760.04). (D) Mean daily voluntary wheel running activity over 17 days was
decreased in Brafcko mice (7.5160.23) compared to floxed (9.6360.22). (n.s.: not significant, ***: P,0.001).
doi:10.1371/journal.pone.0035035.g003
Figure 4. GABAA receptor-mediated inhibition is not enhanced in hippocampi of Braf
cko mice. (A) Extracellular recording of population
spikes in CA1 pyramidal cell layer evoked by electrical stimulation of the Schaffer collateral/commissural pathway. Peak amplitudes of population
spikes were normalized before application of GABAA receptor antagonist, picrotoxin (100 mM). Inset depicts individual population spikes recorded at
like-numbered time points of the graph in a control slice. Arrow indicates electrical stimulation of afferent pathway. (B) Whole-cell recording of IPSCs
from CA1 pyramidal cells. Application of diazepam (3 mM) enhanced IPSC amplitude and slowed decay (inset). Effects of diazepam were quantified
with respect to half width, peak amplitude, and area of IPSC. Histograms did not reveal any differences between genotypes.
doi:10.1371/journal.pone.0035035.g004
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to circadian rhythm (Per2, Bdnf, Cck). Using biological replicates
from mutants and controls of the same sex and age this reanalysis
confirmed the microarray results in all 22 cases (Table S2).
To further identify genes that are directly controlled by ERK/
MAPK signaling, the promoter regions of all 111 differentially
downregulated genes were analyzed in silico for binding sites of the
two major ERK-dependent transcription factors CREB1 and
ELK1. Furthermore, we analyzed the evolutionary conservation of
these motifs, assuming that a wide conservation indicates the
central function of a gene in neuronal ERK/MAPK signaling
[34]. We identified nine genes with at least one binding site for
CREB1 or ELK1 that were conserved between two or more
species (Table 1; for more detailed results see Table S3). The
promoters of four of these genes show sites for both transcription
factors, four genes harbor only CREB1 sites and one gene contains
only an ELK1 site. Interestingly, highly conserved CREB1 sites
($4 orthologs) were found in the promoters of the somatostatin
(Sst), glutamate receptor 3 (Gria3), dual specificity phosphatase 4
(Dusp4), early growth response 1 (Egr1), D15Wsu169e, and brain
derived neurotrophic factor transcript variant 3 (Bdnf) genes of up
to eight mammalian species. Highly conserved ELK1 sites were
identified in the promoters of Dusp4, Egr1, zinc finger protein 326
(Zfp326), and dual specificity phosphatase 5 (Dusp5) (Table 1 and
Table S3). The expression levels of six of these genes was
reanalyzed by qPCR and revealed the reduction of transcripts in
the hippocampus of Brafcko mice by 12%–78% (Table S2).
While Dusp4, Dusp5, Egr1, and Egr4 are known targets of ERK-
dependent transcription in the CNS, the other targets are newly
described. Interestingly, Sst, Gria3, Egr1, and Bdnf have been
previously linked to emotional behavior as well as to LTP and
memory, indicating a connection of these processes by MAPK
stimulated gene expression.
Discussion
ERK/MAP kinase signaling has been implicated in brain
development, long-term memory, and in the response to
antidepressants. Conditional Braf knockout mice enabled us to
unravel a new role of ERK/MAPK signaling for emotional
behavior. Braficko/juvenile and Brafcko mutants, that complete Braf
inactivation in principle forebrain neurons by the age of 4 or 6
weeks respectively, exhibited decreased anxiety-like behavior in
the LD and EPM. We focused the further analysis of the mutant’s
phenotype on the hippocampus since this region has been shown
to play an important role in emotional processing [35–37].
Since inhibitory GABAergic neurotransmission is a key modifier
of anxiety, the anxiolytic phenotype of Brafcko mice might have
been caused by an increased release of GABA or an enhanced
response of GABAA receptors. A direct negative regulation of
GABAA receptors by ERK mediated phosphorylation has been
demonstrated in vitro for the a1 subunit [29]. However, the analysis
of GABAergic neurotransmission revealed the normal function of
this system in the hippocampus of Brafcko mice and does not
explain their anxiolytic phenotype. A major function of ERK/
MAPK signaling is the regulation of gene expression by the
activation of the transcription factors CREB1 and ELK1. Gene
expression analysis in the hippocampus of Brafcko mutants
revealed numerous up- or downregulated transcripts that could
account for the behavioral and morphological phenotypes of these
mutants. To identify the direct transcriptional targets of neuronal
ERK/MAPK signaling, we analyzed the promoter regions of all
differentially downregulated transcripts for the presence of CREB1
and ELK1 binding motifs. This analysis revealed an evolutionary
conserved group of nine transcripts that can be regarded as the
core of ERK/MAPK responsive genes in hippocampal neurons.
Figure 5. Neuronal morphology of granular neurons in dentate gyrus of Brafcko mice. (A) Camera lucida drawings of representative
granule neurons of Brafcko controls and mutants. (B) Total and mean length of dendrites was significantly reduced in granular neurons of Braf
deficient mice. (C,D) Spine density and tortuosity were not altered due to Braf knockout. (error bars: 95% confidence interval; n.s.: not significant, *:
P,0.05) (E,F) Sholl analysis of the dendritic branching revealed an overall reduction of complexity of the granular neurons. Number of intersections
(E) and dendritic length (F) were significantly reduced in the distance of 80–120 and 140–160 mm (intersections) and 90–120 and 150–160 mm
(dendritic length) from soma, respectively (T: tendency, *: P,0.05).
doi:10.1371/journal.pone.0035035.g005
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Besides the immediate early genes Egr1/Egr4 and the regulatory
phosphatases Dusp4/Dusp6, which are known targets of MAPK
signaling, we identified five genes that were previously unrecog-
nized as ERK/MAPK targets. Three of these genes, early growth
response 1 (Egr1), somatostatin (Sst), and brain-derived neuro-
trophic factor (Bdnf, transcript 3), are of particular interest since
they play a role in neuronal activity and behavioral modification.
Mutant mice with a complete depletion of the transcription factor
Egr1 show a strong anxiolytic phenotype in the elevated plus maze
[38]. In Braf mutants, that exhibit reduced levels of Egr1 mRNA, a
similar effect was found in the two anxiety-related behavior tests.
The somatostatin system subserves neuromodulatory roles in the
brain, influencing motor activity, sleep, sensory processes, and
cognitive functions. Sst expression has been found altered in
bipolar disorder [39] and shown to control the migration of
developing neurons [40]. A deficiency of mature BDNF and its
receptor TrkB has been implicated in increased anxiety-related
behavior and decreased neuronal complexity of hippocampal
neurons [31,41]. In Brafcko mice, we observed a reduction of the
Bdnf transcript variant 3 that initiates at the Bdnf promoter IV.
This promoter was shown to be an initial target in the therapeutic
action of the mood stabilizers lithium and valproic acid [42].
Furthermore, ERK/MAPK signaling has been found in vitro to act
as positive regulator of dendritogenesis [43] and reduced neuronal
complexity is also found in Bdnf and TrkB mutants. These mutants,
however, exhibit increased anxiety behavior [31,41]. In future
studies it would be therefore interesting to further study the role of
BDNF in mediating emotional behavior in Braf mutants and to
investigate whether Brafmutants are still sensitive to antidepressant
treatment or whether the loss of ERK/MAPK signaling and
subsequent Bdnf inactivation prevent their action.
Finally, Mozhui et al. [44] found a correlation between stress-
induced alterations in anxiety-related behavior and the Grin2a
NMDA receptor, a known upstream activator of the ERK/MAPK
pathway, which was accompanied by an overlap in gene
expression alterations.
It is therefore possible that the reduced expression of these
‘‘core’’ genes and their downstream targets cause the altered
anxiety behavior, but also the reduced neuronal complexity and
the fragmented activity during the sleep period of Brafcko mice.
However, at present we cannot attribute the action of individual
regulated genes directly to specific phenotypes of Brafcko mice. As
shown for C. elegans, ERK/MAPK controlled biological pheno-
types are mediated by functional groups of 2–10 interacting
proteins [45].
The fragmented activity pattern of Brafcko mice and their
increased activity during the resting phase may represent a
disturbance of sleep, e.g. a delayed sleep onset. Since the
disruption of sleep and circadian activity are associated with
psychiatric disorders [46] it will be interesting to further study the
sleeping behavior of Braf mutants and to investigate in inducible
Braficko mice whether the fragmented activity phenotype results
from developmental effects. Despite the alterations in gene
expression, neuronal morphology, and reduced anxiety, Brafcko
mice exhibited normal depression-like behavior as measured by
the FST and TST paradigms that are used to assess behavioral
despair [47].
The influences of developmental gene knockouts on anxiety-
related behavior have been widely discussed [48], and the early
postnatal period has been found critical for the development of
neural circuits that mediate anxiety and suggest the neurodevel-
opmental origin of anxiety disorders [49]. Using inducible 5-
HT1AR deficient mice, it has been shown that adults exhibit
increased anxiety if 5-HT1AR is absent during the third and fourth
postnatal week, but not if it is absent in the adult brain [50].
During the postnatal period, the hippocampal neurocircuitry is
rapidly maturing. For example, the development of basal and
apical dendrites is achieved during the first to fourth week of life
[51]. In addition, the formation of axonal terminals and dendritic
spines in the hippocampal CA1 region is not completed before day
24 [52]. Since Braf becomes inactivated in Brafcko mice 2–6 weeks
after birth, we asked whether the anxiolytic phenotype of these
mutants originates from postnatal developmental alterations. We
compared inducible mutants that underwent Braf inactivation
either in the early postnatal development or the adult brain. We
found that the anxiolytic phenotype occurred only in Braf mutants
that were induced at 3 weeks but not at the age of 9 weeks. This
result suggests that a juvenile ERK/MAPK deficiency in forebrain
Table 1. Bioinformatic prediction of CREB1 and ETS/SRF target genes.
Gene symbol
microarray (fold
change)
qPCR (fold
change) Binding site (BS) # of species
Conserved BS per
Module
Sst 21.80 n.t. CREB1 10 2
Gria3 21.34 21.14 CREB1 8 1
Dusp4 21.86 22.86 CREB1 8 1
ETS/SRF 7 1
Egr1 22.13 23.57 CREB1 6 2
ETS/SRF 4 4
D15Wsu169e 21.29 n.t. CREB1 6 1
ETS/SRF 2 1
Zfp326 21.36 n.t. ETS 5 1
Bdnf (transcript variant 3) 21.41 22.27 CREB1 4 1
Dusp5 21.90 23.33 CREB1 3 1
ETS/SRF 4 1
Egr4 22.24 22.94 CREB1 3 2
Differentially downregulated genes from Brafcko mice were analyzed for the presence of evolutionary conserved CREB1 and ETS/SRF target sites. Nine genes were found
representing putative functional ERK/MAPK pathway effectors (for more detailed results, see Table S3). (n.t.: not tested).
doi:10.1371/journal.pone.0035035.t001
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principle neurons leads to long-lasting neurodevelopmental
alterations that cause reduced anxiety in adults, providing further
evidence for the postnatal period as critical for the establishment of
normal anxiety behavior. As found for 5-HT1AR [50], in the adult
brain ERK/MAPK signaling is not directly linked to anxiety.
Therefore, it will be of interest to further study whether the
anxiolytic phenotype of juvenile Braf mutants may be linked to
alterations in serotonergic neurotransmission. In contrast to
Braficko/juvenile and Brafcko mice, Braficko/adult mutants exhibited
reduced activity in the FST, suggesting that in the adult brain,
ERK/MAPK signaling plays a role in the modulation of
depression-like behavior. This finding is consistent with previous
observations that associated ERK/MAPK signaling with depres-
sion-like behavior in adult mice and rats. Treatment of mice with
the MEK inhibitor PD184161 increases depression-like behavior
[13] whereas an increase of ERK/MAPK signaling was found
upon treatment with the mood stabilizers lithium [14,15] and
valproic acid [15,16]. In addition, it has been recently described
that depressive subjects exhibit an increased activity of the MAPK
phosphatase MKP-1 and that MKP-1 overactivity causes
depressive behaviors in rodents [53]. Our results confirm the
direct relationship of ERK/MAPK signaling and depression-like
behavior but restrict this relation to the adult brain. The functional
redirection of ERK/MAPK signaling may be mediated by distinct
sets of activator and effector molecules that transduce different
signals in the juvenile versus the adult brain. The ERK/MAPK
pathway is known to be activated during embryogenesis by
fibroblast growth factor receptors (FGFR) [54], while in the adult
brain CRH receptor 1 and glucocorticoid receptor were shown to
activate ERK [55,56]. All of these receptors have been implicated
in the modification of anxiety- and depression-like behavior, but
further studies are required to define which of these receptors, or
other receptors, are coupled to the ERK/MAPK pathway in the
juvenile brain.
Our study is the first reporting a role of neuronal ERK/MAPK
signaling for anxiety-like behavior in juvenile brain development
and for depression-like behavior in the adult brain. The latter
finding confirms that ERK/MAPK signaling is essential for the
expression of normal behavior in the FST. Therefore, the MAP
kinase phosphatases MKP-2, -3, -4, or -6, which mediate negative
feedback inhibition of ERK kinases [57], may represent new
targets for the development of antidepressive drugs. Given the
effect of ERK/MAPK on emotional behavior, the genes that
constitute this pathway could also play a role in the etiology of
mental disorders. Our results suggest that alleles for Braf and other
members of the ERK/MAPK pathway may represent risk factors
for the development of psychiatric diseases, either by copy number
variations in affected genotypes [58] or by altered epigenetic
control of gene expression.
Besides the Brafcko and Braficko/juvenile mutants, various
knockout mouse models exhibit reduced adult anxiety-like
behavior, like conditional mutants for Crhr1 or the glucocorticoid
receptor Nr3c1 gene [59,60]. Since gene inactivation in these
models occurs before or during juvenile brain development by the
use of noninducible Cre driver lines, it is possible that phenotypes
reported from such early postnatal mutants represent develop-
mental alterations and do not report the functional role of these
genes in the adult brain.
Our results provide the first demonstration that an inducible,
Cre/loxP-based conditional mutant allows to differentiate between
gene function in the juvenile and adult brain. The future
application of inducible gene inactivation in the brain is greatly
facilitated by the International Knockout Mouse Consortium
(IKMC, www.knockoutmouse.org) that provides Cre/loxP condi-
tional alleles in ES cells and mice on a genome-wide scale.
Moreover, since knockout mice are also used for the validation of
drug targets [61], inducible gene inactivation could allow a better
prediction of the action of future drugs in the adult brain. Our
results from Braficko mice show that inducible gene inactivation
faithfully reports on gene function in the adult brain and provides
a valuable tool to study the genetic basis of psychiatric diseases.
Supporting Information
Figure S1 Structure of the Brafflox allele and expression
pattern analysis of the CamkIIa-CreERT2 mouse. (A) In
the Brafflox allele, exon 14 of Braf is flanked by two Cre
recombinase recognition (loxP) sites. Cre mediated excision of
this exon leads to a reading frame shift and the production of a
truncated, non-functional BRAF protein. (B) CamkIIa-CreERT2
mice were bred with the Gt(ROSA)26Sor Cre reporter line that
exhibits b-galactosidase activity upon Cre recombination. Strong
recombinase activity was observed in the cortex and hippocampus.
Medium activity was found in striatum and hypothalamus. No
differences for the induction ability of the CreERT2 were found
between the 3rd, 6th, and 14th week of age.
(PDF)
Figure S2 Molecular characterization of CamkIIa-Cre
and Brafcko mice. (A) Using a Cre reporter strain (Soriano,
1999), we confirmed the activity of the CamkIIa-Cre transgene in
principle forebrain neurons (olfactory bulb (oB), cortex (Cx),
hippocampus (Hc), and striatum (St)) and further observed
recombination in the hypothalamus (Ht) and inferior colliculus
(Ic), but not in the thalamus (Th), hindbrain (Hb), brainstem (Bs),
or cerebellum (Cb). (B) Using Southern blot analysis of genomic
DNA (Method S1), we found that the inactivation of Braf in the
hippocampus and cortex (data not shown) of Brafcko mice begins 2
weeks after birth and is complete at the age of 6 weeks. (C) In
Western blots from adult mutants, we observed strongly reduced
BRAF levels in forebrain regions, a lower reduction in the
midbrain, and no reduction in the brainstem and the cerebellum
of Brafcko mice. (D–H) As shown by immunohistochemistry, the
BRAF protein was absent from the glutamatergic neurons of the
dentate gyrus (D, E), the hippocampus (F), and the cortex of
mutant mice (G). In contrary, BRAF signals in cerebellum (H) and
in parvalbumin-positive interneurons of the hippocampus were
comparable to controls (I).
(PDF)
Figure S3 Behavioral analysis of CamkIIa-Cre mice. 29
CamkIIa-Cre mice and 29 littermate controls (lacking the Cre
transgene) were analyzed and no alterations in locomotion, social
interaction, object recognition, anxiety- and depression-related
behavior, and motorcoordination were found in the modified hole
board (A–F), the elevated plus maze (G), the forced swim test (H),
and the accelerating rotarod (I). Data of male and female subjects
were pooled as no sex differences were found. (n.s.: not significant,
*: P,0.05).
(PDF)
Figure S4 GABAA receptor-mediated inhibition is not
enhanced in hippocampi from Brafcko mice. (A) Ampli-
tudes of CA1 population spikes (extracellular recording) are
plotted as function of stimulus intensity to determine input-output
relationship. (B–D) are from whole-cell recordings of CA1
pyramidal cells. (B) Input-output relationship for evoked IPSCs
showed reduced response in CA1 pyramidal cells of Brafcko mice
to nearby electrical stimuli delivered close to pyramidal cell layer
compared to evoked IPSC responses in control cells (*: p,0.05).
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(C) Train stimuli (delivered at 20 Hz, inset) revealed no significant
difference in frequency depression during train between mutant
and control neurons. The histogram plots normalized IPSC
amplitude relative to amplitude of first IPSC. (D) The GABAA
receptor agonist muscimol (1 mM) induced similar postsynaptic
currents in mutant and control neurons (left columns, p.0.05).
Inset illustrates representative muscimol-evoked current response
in a control neuron. Downward deflections in the trace reflect
spontaneous IPSCs (sp IPSCs), which occurred at about the same
frequency in neurons from both lines of mice (right columns,
p.0.05).
(PDF)
Table S1 Gene expression analysis of hippocampal
RNA of adult Brafcko mice revealed 165 differentially
expressed transcripts (124 downregulated, 41 upregu-
lated, P,0.05). In total, 150 individual genes were affected, 111
were downregulated and 39 were upregulated. (#: transcripts were
found to be also regulated in CamkIIa-Cre controls and therefore
excluded from further studies).
(PDF)
Table S2 qPCR validation of 22 candidate genes from
the microarray results. Genes were classified by gene ontology
and MeSH analysis. (*: mean values due to multiple transcripts
detected in microarray; s.d.: standard deviation).
(DOC)
Table S3 Bioinformatic prediction of CREB1 and ETS/
SRF target genes. *: position relative to transcription start site
(TSS); #: Hs, Homo sapiens (human); Mm, Mus musculus
(mouse); Rn, Rattus norvegicus (rat); Cfa, Canis lupus familiaris
(dog); Bt, Bos taurus (cattle); Eca, Equus caballus (horse); Pt, Pan
troglodytes (chimpanzee); Mmu Macaca mulatta (rhesus monkey);
Ssc, Sus scrofa (wild boar); Gga, Gallus gallus (chicken); Mdm,
Monodelphis domestica (short-tailed opossum); Dr, Danio rerio
(zebrafish); 1: binding sites both on sense and antisense strand; x:
sequences aligned in the region of the ETS binding site. All gene
symbols, promoter, and transcript identifier were derived from the
promoter sequence retrieval database ElDorado (Genomatix,
Munich, Germany). Selection of putative target genes was based
on significantly downregulated genes from microarray datasets of
Brafcko and control mice. Promoter sequences from up to ten
different mammalian species were aligned with the DiAlign TF
program in the Genomatix software suite GEMS Launcher to
evaluate overall promoter similarity and to identify conserved
CREB1 and ETS/SRF binding sites (BSs). The promoter regions
were defined as,900 bp upstream and 100 bp downstream of the
transcriptional start site (TSS). Position weight matrices were used
according to Matrix Family Library Version 8.1 (June 2009) for
promoter analyses. BS or combination of BSs (i.e. Module) were
considered as ‘‘conserved BS/Module’’ only if the promoter
sequences for all given orthologs could be aligned in the region of
CREB1 BS or ETS/SRF Module with the help of the DiAlign TF
program (using default settings). The ETS/SRF module was
defined by the ModelInspector (Genomatix/GEMS Launcher)
with a distance of 9 to 19 bp between the ETS and the SRF BS
and was tested for its presence in the c-fos promoter of different
species. The genes in the first column were ranked by the degree of
conservation of predicted CREB1 BS or ETS/SRF module across
ten mammalian species. The higher the amount of conserved sites
in an increasing number of orthologous promoter sequences, the
higher is the rank of the corresponding gene listed from top to
bottom.
(PDF)
Method S1 Southern blot analysis.
(PDF)
Method S2 Behavioral testings: Modified hole board
and Accelerating rotarod.
(PDF)
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